CN120694962A - 硬胶囊剂型和其用途 - Google Patents
硬胶囊剂型和其用途Info
- Publication number
- CN120694962A CN120694962A CN202510867968.2A CN202510867968A CN120694962A CN 120694962 A CN120694962 A CN 120694962A CN 202510867968 A CN202510867968 A CN 202510867968A CN 120694962 A CN120694962 A CN 120694962A
- Authority
- CN
- China
- Prior art keywords
- dosage form
- capsule
- hydroxyvitamin
- formulation
- hard
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032714P | 2020-05-31 | 2020-05-31 | |
| US63/032,714 | 2020-05-31 | ||
| WOPCT/IB2021/000220 | 2021-04-06 | ||
| PCT/IB2021/000220 WO2021205225A1 (en) | 2020-04-06 | 2021-04-06 | 25-hydroxyvitamin d for the treatment of sars-cov-2 infection |
| PCT/IB2021/000376 WO2021245458A1 (en) | 2020-05-31 | 2021-05-31 | Hard capsule dosage form and uses thereof |
| CN202180038341.6A CN115768412A (zh) | 2020-05-31 | 2021-05-31 | 硬胶囊剂型和其用途 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180038341.6A Division CN115768412A (zh) | 2020-05-31 | 2021-05-31 | 硬胶囊剂型和其用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN120694962A true CN120694962A (zh) | 2025-09-26 |
Family
ID=78831505
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202510867968.2A Pending CN120694962A (zh) | 2020-05-31 | 2021-05-31 | 硬胶囊剂型和其用途 |
| CN202180038341.6A Pending CN115768412A (zh) | 2020-05-31 | 2021-05-31 | 硬胶囊剂型和其用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180038341.6A Pending CN115768412A (zh) | 2020-05-31 | 2021-05-31 | 硬胶囊剂型和其用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20230293552A1 (https=) |
| EP (1) | EP4157231A1 (https=) |
| JP (1) | JP2023526980A (https=) |
| KR (1) | KR20230017192A (https=) |
| CN (2) | CN120694962A (https=) |
| AU (1) | AU2021285494A1 (https=) |
| CA (1) | CA3181945A1 (https=) |
| IL (1) | IL297885A (https=) |
| WO (1) | WO2021245458A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120694962A (zh) * | 2020-05-31 | 2025-09-26 | 艾尔金制药有限公司 | 硬胶囊剂型和其用途 |
| CN119907688A (zh) * | 2022-09-20 | 2025-04-29 | 比利时胶囊公司 | 含有氧化镁的遮光硬胶囊 |
| WO2025094144A1 (en) | 2023-11-02 | 2025-05-08 | Eirgen Pharma Ltd. | Controlling loss of kidney function |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264223A (en) | 1990-03-29 | 1993-11-23 | Japan Elanco Company, Ltd. | Hard capsule for pharmaceutical drugs and method for producing the same |
| US5431917A (en) | 1992-10-08 | 1995-07-11 | Japan Elanco Company, Ltd. | Hard capsule for pharmaceutical drugs and method for producing the same |
| US5756123A (en) * | 1994-12-01 | 1998-05-26 | Japan Elanco Co., Ltd. | Capsule shell |
| FR2757173A1 (fr) | 1996-12-17 | 1998-06-19 | Warner Lambert Co | Compositions polymeres d'origine non-animale pour la formation de films |
| KR100379674B1 (ko) | 2000-03-06 | 2003-04-10 | 주식회사 서흥캅셀 | 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법 |
| CA2519208A1 (en) * | 2003-03-17 | 2004-09-30 | Takeda Pharmaceutical Company Limited | Controlled release composition |
| ES2593047T3 (es) | 2006-02-03 | 2016-12-05 | Opko Renal, Llc | Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3 |
| ES2670029T3 (es) * | 2006-06-21 | 2018-05-29 | Opko Ireland Global Holdings, Ltd. | Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D |
| CN101595133B (zh) * | 2006-10-27 | 2012-11-14 | 比利时胶囊公司 | 羟丙基甲基纤维素硬胶囊及制备方法 |
| KR20190028822A (ko) * | 2007-04-25 | 2019-03-19 | 사이토크로마 인코포레이티드 | 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물 |
| HUE073014T2 (hu) * | 2007-04-25 | 2025-12-28 | Opko Renal Llc | Eljárás a másodlagos hyperparathyreoidismus biztonságos és hatékony kezelésére és megelõzésére krónikus vesebetegség esetén |
| EP2321273B1 (en) * | 2008-07-24 | 2014-11-19 | Wisconsin Alumni Research Foundation | Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration |
| US8852631B2 (en) * | 2009-09-24 | 2014-10-07 | Capsugel Belgium Nv | Acid resistant capsules |
| KR20140072715A (ko) * | 2012-12-05 | 2014-06-13 | 삼성정밀화학 주식회사 | 경질 캡슐 |
| JP2014172850A (ja) * | 2013-03-07 | 2014-09-22 | Capsugel Belgium Nv | ハードカプセル製剤 |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) * | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| JP7032322B2 (ja) * | 2016-03-28 | 2022-03-08 | オプコ アイルランド グローバル ホールディングス リミテッド | ビタミンｄ治療法 |
| BR112020000011A2 (pt) * | 2017-07-11 | 2020-07-21 | Qualicaps Co., Ltd. | cápsula dura entérica |
| JP7603000B2 (ja) | 2018-08-31 | 2024-12-19 | オプコ アイルランド グローバル ホールディングス リミテッド | ビタミンｄ小児用剤形、製造方法および使用方法 |
| US20210308151A1 (en) * | 2020-04-06 | 2021-10-07 | Eirgen Pharma Ltd. | Activating endogenous antimicrobials to treat sars-cov-2 infection |
| CN120694962A (zh) * | 2020-05-31 | 2025-09-26 | 艾尔金制药有限公司 | 硬胶囊剂型和其用途 |
-
2021
- 2021-05-31 CN CN202510867968.2A patent/CN120694962A/zh active Pending
- 2021-05-31 JP JP2022571817A patent/JP2023526980A/ja active Pending
- 2021-05-31 AU AU2021285494A patent/AU2021285494A1/en active Pending
- 2021-05-31 IL IL297885A patent/IL297885A/en unknown
- 2021-05-31 KR KR1020227041029A patent/KR20230017192A/ko active Pending
- 2021-05-31 EP EP21748934.3A patent/EP4157231A1/en active Pending
- 2021-05-31 CN CN202180038341.6A patent/CN115768412A/zh active Pending
- 2021-05-31 US US18/005,946 patent/US20230293552A1/en active Pending
- 2021-05-31 CA CA3181945A patent/CA3181945A1/en active Pending
- 2021-05-31 WO PCT/IB2021/000376 patent/WO2021245458A1/en not_active Ceased
-
2023
- 2023-05-18 US US18/199,117 patent/US20230330110A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN115768412A (zh) | 2023-03-07 |
| WO2021245458A1 (en) | 2021-12-09 |
| EP4157231A1 (en) | 2023-04-05 |
| KR20230017192A (ko) | 2023-02-03 |
| US20230293552A1 (en) | 2023-09-21 |
| AU2021285494A1 (en) | 2022-12-08 |
| JP2023526980A (ja) | 2023-06-26 |
| US20230330110A1 (en) | 2023-10-19 |
| CA3181945A1 (en) | 2021-12-09 |
| IL297885A (en) | 2023-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102770127B (zh) | 抗滥用制剂 | |
| TWI659753B (zh) | 經穩定之修飾釋放維他命ｄ調配物及其服用方法 | |
| JP5894717B2 (ja) | 乱用抑止性製剤 | |
| JP6312437B2 (ja) | 胃腸管疾患を治療するためのヒドララジン含有免疫調節組成物 | |
| EP4035657B1 (en) | Drug composition containing abiraterone acetate, and preparation method therefor and application thereof | |
| US20230330110A1 (en) | Hard capsule dosage form and uses thereof | |
| AU2021107174A4 (en) | Vitamin d pediatric dosage forms, methods of making and using | |
| CN107405309B (zh) | 用于治疗肥胖症和相关代谢紊乱的奥利司他和阿卡波糖的调释组合物 | |
| RS56890B1 (sr) | Formulacije deferasiroksa za oralnu upotrebu | |
| JP6915258B2 (ja) | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 | |
| WO2024218722A2 (en) | Compositions and methods for the treatment of coenzyme q10 deficiency | |
| TWI645864B (zh) | 經穩定之修飾釋放維他命ｄ調配物及其服用方法 | |
| TWI743426B (zh) | 經穩定之修飾釋放維他命d調配物及其服用方法 | |
| EA052626B1 (ru) | Лекарственные формы для применения в педиатрии, способы получения и применения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |